日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry

接受度普利尤单抗治疗的未控制重度哮喘青少年患者的特征:PEDIASTHMA 注册研究

Wanin, Stéphanie; Taam, Rola Abou; Chami, Lisa Giovannini; Marguet, Christophe; Just, Jocelyne; Da Silva, Christele; Msihid, Jérôme; Ledanois, Olivier; Gall, Rebecca; Sacks, Harry J; Jacob-Nara, Juby A; Daridon, Capucine; Deschildre, Antoine

Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies

Dupilumab 改善结节性痒疹成人患者的日常症状负担:LIBERTY PN-PRIME 和 PRIME2 研究的事后分析

Kwatra, Shawn G; Ständer, Sonja; Kim, Brian S; Msihid, Jerome; Bansal, Ashish; Makhija, Melanie; Wiggins, Simmi; Zahn, Joseph; Thomas, Ryan B; Bahloul, Donia

Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria

度普利尤单抗可改善未接受过奥马珠单抗治疗的慢性自发性荨麻疹患者的健康相关生活质量

Giménez-Arnau, Ana M; Casale, Thomas B; Yosipovitch, Gil; Ensina, Luis Felipe; Inomata, Naoko; Msihid, Jérôme; Makhija, Melanie; Radin, Allen; Cyr, Sonya L; Sugerman, Philip; Thomas, Ryan B; Chuang, Chien-Chia

Clinically meaningful improvements in treatment satisfaction in insulin-naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real-world ATOS study

在开始使用甘精胰岛素 300 U/mL 后,2 型糖尿病初治患者的治疗满意度得到具有临床意义的改善:一项基于真实世界 ATOS 研究的事后分析

Snoek, Frank; Galstyan, Gagik; Khan, Niaz; Tirosh, Amir; Kesavadev, Jothydev; Vargas-Uricoechea, Hernando; Baghous, Houssem; Mabunay, Maria Aileen; Grulovic, Natasa; Corp Dit Genti, Valerie; Msihid, Jerome; Harris, Stewart

A Method for Adjusting EQ-5D-3L Health State Utilities for Cross-Country Use: Application of a Novel US-to-UK Utility Mapping Approach

一种调整 EQ-5D-3L 健康状态效用值以适应跨国使用的方法:一种新型的美国到英国效用映射方法的应用

Omar Alsaleh, Abdul Jabbar; Msihid, Jerome; Lew, Elisheva; Nicholls, Charlie

Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials

结节性痒疹最严重瘙痒程度数字评分量表:两项随机临床试验的二次分析

Kwatra, Shawn G; Yosipovitch, Gil; Kim, Brian; Stander, Sonja; Rhoten, Stephanie; Ivanescu, Cristina; Haeusler, Nadine; Brookes, Ella; Msihid, Jerome; Makhija, Melanie; Bansal, Ashish; Thomas, Ryan B; Bahloul, Donia

Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension

长期使用舒替利单抗治疗冷凝集素病患者后,患者报告结局持续改善:CADENZA 研究开放标签扩展研究的结果

Röth, Alexander; Broome, Catherine M; Barcellini, Wilma; Jilma, Bernd; Hill, Quentin A; Cella, David; Anderson Tvedt, Tor Henrik; Yamaguchi, Masaki; Murakhovskaya, Irina; Lee, Michelle; Shafer, Frank; Wardęcki, Marek; Jayawardene, Deepthi; Yoo, Ronnie; Msihid, Jerome; Weitz, Ilene C

Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial

Dupilumab治疗韩国中心招募的未控制的中重度哮喘患者的长期安全性和有效性:LIBERTY ASTHMA TRAVERSE III期试验的亚组分析

Rhee, Chin Kook; Park, Jung-Won; Park, Heung-Woo; Noh, Hayeon; Msihid, Jerome; Cho, You Sook

Efficacy of avalglucosidase alfa on forced vital capacity percent predicted in treatment-naïve patients with late-onset Pompe disease: A pooled analysis of clinical trials

阿伐葡萄糖苷酶α对初治晚发型庞贝病患者用力肺活量占预计值的百分比的影响:一项临床试验汇总分析

Mozaffar, Tahseen; Riou França, Lionel; Msihid, Jérôme; Shukla, Pragya; Proskorovsky, Irina; Zhou, Tianyue; Periquet, Magali; An Haack, Kristina; Pollissard, Laurence; Straub, Volker

Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study

Dupilumab 可改善儿童哮喘控制并提高生活质量:VOYAGE 研究

Fiocchi, Alessandro G; Phipatanakul, Wanda; Zeiger, Robert S; Durrani, Sandy R; Cole, Jeremy; Msihid, Jérôme; Gall, Rebecca; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J; Lederer, David J; Hardin, Megan; Zhang, Yi; Khan, Asif H